Compare Freshworks Inc (FRSH) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freshworks Inc vs Nuwellis Inc — how do they compare? Freshworks Inc trades at $12.55 (market cap $3.22B), while Nuwellis Inc trades at $1.38 (market cap $515.48K). The key difference: Freshworks Inc is far larger — about 6246.6× Nuwellis Inc's market cap, and Freshworks Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| FRSH | NUWE | |
|---|---|---|
Market Cap | $3.22B | $515.48K |
Sector | Technology | Technology |
52-Week High | $13.97 | $220.50 |
52-Week Low | $6.88 | $1.30 |
Enterprise Value | $2.59B | -$1.29M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Freshworks (FRSH) trades at $12.68, up 5.93% with bullish technical signals and strong fundamental momentum. The company reported Q2 2026 revenue of $237.4 million, beating estimates with 16% YoY growth, achieving its first GAAP profitability quarter. Analyst consensus shows 50% buy ratings with a $16.50 price target, representing 30% upside potential. Recent FedRAMP certification and Gartner leadership recognition strengthen the company's competitive positioning in AI-powered service operations.
The outlook remains positive with accelerating revenue growth and improving profitability, though valuation multiples remain elevated. Key risks include execution challenges in multi-product expansion and competitive pressure in the SaaS sector. The stock presents a compelling opportunity for growth investors seeking exposure to the enterprise software market with improving fundamentals and strong analyst support.
NUWE trades at $1.41, down 4.73% on the day, with a bearish technical signal from moving averages despite bullish oscillators. The company reported revenue growth of 14% year-over-year for Q2 2026 (GlobeNewsWire, 2026-07-27) but continues to post significant net losses, with a net income margin of -217.22%. Recent developments include a reverse stock split, a new CEO appointment, and capital raises extending the cash runway into Q2 2027.
The outlook remains high-risk due to persistent losses and negative profitability metrics, though revenue growth and strategic expansions in pediatric care offer potential. Investment opportunity hinges on the company's ability to achieve profitability; key risks include cash burn, competitive pressures, and execution challenges in scaling the Aquadex platform.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Freshworks Inc
Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CX and ITSM categories, and have also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and better serve their customers and employees.
Read more on FRSH →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
